Global Inhalation Anesthesia Market By Product Type (Apparatus, Anesthetics (Isoflurane, Sevoflurane, Desflurane, Nitrous Oxide, Others), Accessories); By Application (Human Healthcare (0 to 1 Months, 1 to Less Than 6 Months, 6 Months to Less Than 3 Years, 3 to 12 Years, 12 to 25 Years, 25 to 50 Years, More than 50 Years), Veterinary Healthcare); By End User (Hospitals, Clinics, Ambulatory Surgical Centres, Others); By Region (U.S., Canada, Mexico, Rest of North America, The UK, France, Germany, Italy, Spain, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, the Netherlands, Luxembourg), Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2019 - 2027

Report ID :AMI-571 | Category : Healthcare | Published Date : April, 2020 | Pages : 402 | Format :PDF

Industry Trends

The growing number of medical procedures and surgeries across the globe has increased the demand for sedation for painless treatment delivery among patients. Anesthetics are the drugs used for sedating a patient temporarily, which makes patient loose sensation of a particular area of body or whole. The application of anesthesia is majorly of three types, namely Local (numbs small area of the body), Regional (numbs specific part of the body) and General (makes patient unconscious and painless). The type of anesthesia delivered depends on factors such as type of procedure, medical conditions and others. Anesthesia can be administered by intravenous method or by inhalation. Volatile anesthetics are used for general anesthesia to exert and maintain their effects through central nervous system. The first use of inhalation anesthesia dates back to 1840s, when ether, chloroform, and nitrous oxides were the early anesthetic agents used in inhalation delivery. Safety issues with these early agents were recognized later and hydrocarbon based anesthetics became highly popular since then. The inhalational anesthesia administration is done through equipment such as face mask, laryngeal mask airway or tracheal tube which are connected to an anaesthetic delivery system. Compared to intravenous anesthetic delivery, inhalation anesthesia has advantages such as accurate administration, access to circulation, pharmacokinetic and pharmacodynamics exactness which makes inhalational anesthesia more reliable. The rising number of surgeries coupled with the advantages of inhalational anesthetics over intravenous anesthetics has propelled the growth of global inhalation anesthesia market.

The recent outbreak of COVID-19 has hit the world with a total of more than 5 million affected patients and a death toll of more than 320,000 people across the globe. There is a daily rise of about 100,000 global patients as per the latest release by World Health Organization in May 2020, which has increased the pressure on healthcare infrastructure and medical care givers of the affected countries. The primary cause of deaths in COVID-19 affected patients is acute respiratory distress syndrome (ARDS). Amidst absence of a proven effective cure for the coronavirus infection, current treatments are mainly supported by the ICUs of hospitals flooding around the world with patients. Researchers and medical experts are claiming that inhalation of volatile anesthetics can be a vital supplementary treatment for COVID-19. As the number of patients are increasing, ICUs of hospitals require sedation and intravenous sedation is most commonly preferred which has caused a shortfall of these drugs forcing doctors to take alternative sedation methods. Inhalation anesthetics have faster onset and offset, reduced hallucinations and enables faster discharge from the ICUs which is a vital aspect considering the increasing flow of patients. Owing to the short wake-up along with rapid cognitive recovery, inhalation anesthetics have been increasingly used by healthcare professional across the globe to treat COVID-19 patients, thus boosting growth of inhalation anesthesia market, across the globe.

Product Type:

Based on the type of products, anesthetics held largest share of global inhalation anesthesia market in 2018 and is expected maintain this dominance over the forecast period. Apparatus being a non-consumable type of product does not need frequent replacements but anaesthetics do. Anaesthetic drugs used in inhalation delivery have evolved from chloroform to hydrocarbon based overcoming the limitations of early anesthetics. The most commonly used types of inhalation anesthetics are Isoflurane, Sevoflurane, Desflurane and Nitrous Oxide amongst others owing to their rapid onset action and the also quicker recovery of patients with less hallucinations. Isolurane is the most popular inhalation anesthetic drug with highest market share in 2018 and is also anticipated to grow at a higher rate over the forecast period owing to low solubility coefficient which makes its induction and recovery faster. Also, Isoflurane preserves the cardiac function and heart rate which makes it preferable anesthetic drug in cardiac surgeries. These benefits of inhalation anesthetic drugs have propelled the growth of global inhalation anesthesia market thus making them increasingly preferable of intravenous anesthetics.

Application Outlook

Based on type of application, veterinary healthcare led the global inhalation anesthesia market in 2018 and is anticipated to show highest growth rate over the forecast years. The rising pet population across the globe has contributed towards increase in veterinary healthcare and thus increased the animal surgeries and anesthetic requirements. The American Pet Products Association in their press release of May 2019 stated that over two thirds of U.S households have pets with an estimation of 84.9 million homes. They also mentioned that veterinary spending increased by 6.1% to amount US$ 18.11 billion in 2018. Thus the rising veterinary care expenditure coupled with growing pet population is expected to drive the growth veterinary healthcare in global inhalation anesthesia market over the forecast period. However, human healthcare also has a significant share in inhalation anesthesia market with rising surgical procedures undergone by 3 to 12 years of patients. There has been a consistent rise in surgical procedures undergone by school aged children either for dental care, orthopaedic or any other. Thus, the human healthcare is anticipated to contribute a significant share towards the growth of global inhalation anesthesia market over forecast period.

End User Outlook:

Based on the end users, hospital held the major share of global inhalation anesthesia market in 2018 owing to high number of surgeries and treatments requiring anesthesia administration. Clinics are anticipated to show fastest growth over the forecast period owing to rise in dental, cosmetic and other non-critical surgeries. According to a survey report released by International Society of Aesthetic Plastic Surgery (ISAPS) in 2018, more than 23 million cosmetic procedures were performed in 2018 globally with a 15% rise in past four years. These increasing non-critical surgeries performed at clinics are anticipated contribute towards growth of global inhalation anesthesia market over forecast period. Ambulatory surgical centres are rapidly evolving due to changing strategies of medtech companies for delivering healthcare services economically. Ambulatory surgical centres can provide same-day surgical care thus reducing the hospitalization charges and hence are gaining popularity in outpatient care. The economical surgical treatments provided by Ambulatory surgical centres are anticipated to contribute towards growth of global inhalation anesthesia market in future years.

Regional Outlook:

North America region registered the highest share in global inhalation anesthesia market in 2018. The growing old age population in the countries including U.S coupled with developed medical infrastructure in the region has contributed towards the high share of North America in global inhalation anesthesia market. An article released by Population Reference Bureau in July 2019 states that U.S population older than 65 years of age is expected to double in 2060 from 52 million in 2018. The geriatric population contributes highest share of surgeries hence driving the demand in inhalation anesthesia market. Asia Pacific region is anticipated to show highest growth rate in the global inhalation anesthesia market over the forecast years owing to rise in medical tourism and investment in healthcare infrastructure of the region.

In terms of revenue, global inhalation anesthesia market was valued at US$ 12,607.8 Mn in 2018 and is anticipated to reach US$ 20,385.0 by 2027 at a CAGR of 5.5%. The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.

Global Inhalation Anesthesia Market Revenue & Forecast, (US$ Million), 2015 – 2027

Competitive Landscape

The report provides both, qualitative and quantitative research of inhalation anesthesia market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analyzed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.

Some of the players operating in the inhalation anesthesia market are AbbVie Inc., Baxter, BOC, Halocarbon, Hengrui Medicine, Kent Scientific Corporation, Merck KGaA, Midmark Corporation, Piramal Critical Care and Raman & Weil Pvt. Ltd. amongst others.

Click on image to enlarge

Global Inhalation Anesthesia Market:

By Product Type
- Apparatus
- Anesthetics
  - Isoflurane
  - Sevoflurane
  - Desflurane
  - Nitrous Oxide
  - Others
- Accessories

By Application

Human Healthcare
- 0 to 1 Months
- 1 to Less Than 6 Months
- 6 Months to Less Than 3 Years
- 3 to 12 Years
- 12 to 25 Years
- 25 to 50 Years
- More than 50 Years
Veterinary Healthcare
By End User
- Hospitals
- Clinics
- Ambulatory Surgical Centres
- Others

By Geography

North America
- US
- Canada
- Mexico
- Rest of North America
Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
  - Denmark
  - Finland
  - Iceland
  - Sweden
  - Norway
- Benelux Union
  - Belgium
  - The Netherlands
  - Luxembourg
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
  - Indonesia
  - Thailand
  - Malaysia
  - Singapore
  - Rest of Southeast Asia
- Rest of Asia Pacific
Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America

Table of Contents

1. Market Scope

1.1. Market Segmentation

1.2. Years Considered

1.2.1. Historic Years: 2015 - 2017

1.2.2. Base Year: 2018

1.2.3. Forecast Years: 2019 – 2027

2. Key Target Audiences

3. Research Methodology

3.1. Primary Research

3.1.1. Research Questionnaire

3.1.2. Global Percentage Breakdown

3.1.3. Primary Interviews: Key Opinion Leaders (KOLs)

3.2. Secondary Research

3.2.1. Paid Databases

3.2.2. Secondary Sources

3.3. Market Size Estimates

3.3.1. Top-Down Approach

3.3.2. Bottom-Up Approach

3.4. Data Triangulation Methodology

3.5. Research Assumptions

4. Recommendations and Insights from RC’s Perspective**

5. Holistic Overview of Inhalation Anesthesia Market

6. Market Synopsis: Inhalation Anesthesia Market

7. Inhalation Anesthesia Market Analysis: Qualitative Perspective

7.1. Introduction

7.1.1. Product Definition

7.1.2. Industry Development

7.2. Market Dynamics

7.2.1. Drivers

7.2.2. Restraints

7.2.3. Opportunities

7.3. Trends in Inhalation Anesthesia Market

7.4. Market Determinants Radar Chart

7.5. Macro-Economic and Micro-Economic Indicators: Inhalation Anesthesia Market

7.6. Porter’s Five Force Analysis

8. Global Inhalation Anesthesia Market Analysis and Forecasts, 2019 – 2027

8.1. Overview

8.1.1. Global Inhalation Anesthesia Market Revenue (US$ Mn)

8.2. Global Inhalation Anesthesia Market Revenue (US$ Mn) and Forecasts, By Product Type

8.2.1. Apparatus

8.2.1.1. Definition

8.2.1.2. Market Estimation and Penetration, 2015 – 2018

8.2.1.3. Market Forecast, 2019 – 2027

8.2.1.4. Compound Annual Growth Rate (CAGR)

8.2.1.5. Regional Bifurcation

8.2.1.5.1. North America

8.2.1.5.1.1. Market Estimation, 2015 – 2018

8.2.1.5.1.2. Market Forecast, 2019 – 2027

8.2.1.5.2. Europe

8.2.1.5.2.1. Market Estimation, 2015 – 2018

8.2.1.5.2.2. Market Forecast, 2019 – 2027

8.2.1.5.3. Asia Pacific

8.2.1.5.3.1. Market Estimation, 2015 – 2018

8.2.1.5.3.2. Market Forecast, 2019 – 2027

8.2.1.5.4. Middle East and Africa

8.2.1.5.4.1. Market Estimation, 2015 – 2018

8.2.1.5.4.2. Market Forecast, 2019 – 2027

8.2.1.5.5. Latin America

8.2.1.5.5.1. Market Estimation, 2015 – 2018

8.2.1.5.5.2. Market Forecast, 2019 – 2027

8.2.2. Anesthetics (Definition, Market Estimation and Penetration, 2015 – 2018, Market Estimation (2015 – 2018), Market Forecast (2019 – 2027), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Isoflurane, Sevoflurane, Desflurane, Nitrous Oxide, Others)

8.2.2.1. Isoflurane

8.2.2.2. Sevoflurane

8.2.2.3. Desflurane

8.2.2.4. Nitrous Oxide

8.2.2.5. Others

8.2.3. Accessories

8.2.3.1. Definition

8.2.3.2. Market Estimation and Penetration, 2015 – 2018

8.2.3.3. Market Forecast, 2019 – 2027

8.2.3.4. Compound Annual Growth Rate (CAGR)

8.2.3.5. Regional Bifurcation

8.2.3.5.1. North America

8.2.3.5.1.1. Market Estimation, 2015 – 2018

8.2.3.5.1.2. Market Forecast, 2019 – 2027

8.2.3.5.2. Europe

8.2.3.5.2.1. Market Estimation, 2015 – 2018

8.2.3.5.2.2. Market Forecast, 2019 – 2027

8.2.3.5.3. Asia Pacific

8.2.3.5.3.1. Market Estimation, 2015 – 2018

8.2.3.5.3.2. Market Forecast, 2019 – 2027

8.2.3.5.4. Middle East and Africa

8.2.3.5.4.1. Market Estimation, 2015 – 2018

8.2.3.5.4.2. Market Forecast, 2019 – 2027

8.2.3.5.5. Latin America

8.2.3.5.5.1. Market Estimation, 2015 – 2018

8.2.3.5.5.2. Market Forecast, 2019 – 2027

8.3. Key Segment for Channeling Investments

8.3.1. By Product Type

9. Global Inhalation Anesthesia Market Analysis and Forecasts, 2019 – 2027

9.1. Overview

9.2. Global Inhalation Anesthesia Market Revenue (US$ Mn) and Forecasts, By Application

9.2.1. Human Healthcare (Definition, Market Estimation and Penetration, 2015 – 2018, Market Estimation (2015 – 2018), Market Forecast (2019 – 2027), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on 0 to 1 Months, 1 to Less Than 6 Months, 6 Months to Less Than 3 Years, 3 to 12 Years, 12 to 25 Years, 25 to 50 Years, More than 50 Years)

9.2.1.1. 0 to 1 Months

9.2.1.2. 1 to Less Than 6 Months

9.2.1.3. 6 Months to Less Than 3 Years

9.2.1.4. 3 to 12 Years

9.2.1.5. 12 to 25 Years

9.2.1.6. 25 to 50 Years

9.2.1.7. More than 50 Years

9.2.2. Veterinary Healthcare

9.2.2.1. Definition

9.2.2.2. Market Estimation and Penetration, 2015 – 2018

9.2.2.3. Market Forecast, 2019 – 2027

9.2.2.4. Compound Annual Growth Rate (CAGR)

9.2.2.5. Regional Bifurcation

9.2.2.5.1. North America

9.2.2.5.1.1. Market Estimation, 2015 – 2018

9.2.2.5.1.2. Market Forecast, 2019 – 2027

9.2.2.5.2. Europe

9.2.2.5.2.1. Market Estimation, 2015 – 2018

9.2.2.5.2.2. Market Forecast, 2019 – 2027

9.2.2.5.3. Asia Pacific

9.2.2.5.3.1. Market Estimation, 2015 – 2018

9.2.2.5.3.2. Market Forecast, 2019 – 2027

9.2.2.5.4. Middle East and Africa

9.2.2.5.4.1. Market Estimation, 2015 – 2018

9.2.2.5.4.2. Market Forecast, 2019 – 2027

9.2.2.5.5. Latin America

9.2.2.5.5.1. Market Estimation, 2015 – 2018

9.2.2.5.5.2. Market Forecast, 2019 – 2027

9.3. Key Segment for Channeling Investments

9.3.1. By Application

10. Global Inhalation Anesthesia Market Analysis and Forecasts, 2019 – 2027

10.1. Overview

10.2. Global Inhalation Anesthesia Market Revenue (US$ Mn) and Forecasts, By End User

10.2.1. Hospitals

10.2.1.1. Definition

10.2.1.2. Market Estimation and Penetration, 2015 – 2018

10.2.1.3. Market Forecast, 2019 – 2027

10.2.1.4. Compound Annual Growth Rate (CAGR)

10.2.1.5. Regional Bifurcation

10.2.1.5.1. North America

10.2.1.5.1.1. Market Estimation, 2015 – 2018

10.2.1.5.1.2. Market Forecast, 2019 – 2027

10.2.1.5.2. Europe

10.2.1.5.2.1. Market Estimation, 2015 – 2018

10.2.1.5.2.2. Market Forecast, 2019 – 2027

10.2.1.5.3. Asia Pacific

10.2.1.5.3.1. Market Estimation, 2015 – 2018

10.2.1.5.3.2. Market Forecast, 2019 – 2027

10.2.1.5.4. Middle East and Africa

10.2.1.5.4.1. Market Estimation, 2015 – 2018

10.2.1.5.4.2. Market Forecast, 2019 – 2027

10.2.1.5.5. Latin America

10.2.1.5.5.1. Market Estimation, 2015 – 2018

10.2.1.5.5.2. Market Forecast, 2019 – 2027

10.2.2. Clinics

10.2.2.1. Definition

10.2.2.2. Market Estimation and Penetration, 2015 – 2018

10.2.2.3. Market Forecast, 2019 – 2027

10.2.2.4. Compound Annual Growth Rate (CAGR)

10.2.2.5. Regional Bifurcation

10.2.2.5.1. North America

10.2.2.5.1.1. Market Estimation, 2015 – 2018

10.2.2.5.1.2. Market Forecast, 2019 – 2027

10.2.2.5.2. Europe

10.2.2.5.2.1. Market Estimation, 2015 – 2018

10.2.2.5.2.2. Market Forecast, 2019 – 2027

10.2.2.5.3. Asia Pacific

10.2.2.5.3.1. Market Estimation, 2015 – 2018

10.2.2.5.3.2. Market Forecast, 2019 – 2027

10.2.2.5.4. Middle East and Africa

10.2.2.5.4.1. Market Estimation, 2015 – 2018

10.2.2.5.4.2. Market Forecast, 2019 – 2027

10.2.2.5.5. Latin America

10.2.2.5.5.1. Market Estimation, 2015 – 2018

10.2.2.5.5.2. Market Forecast, 2019 – 2027

10.2.3. Ambulatory Surgical Centers

10.2.3.1. Definition

10.2.3.2. Market Estimation and Penetration, 2015 – 2018

10.2.3.3. Market Forecast, 2019 – 2027

10.2.3.4. Compound Annual Growth Rate (CAGR)

10.2.3.5. Regional Bifurcation

10.2.3.5.1. North America

10.2.3.5.1.1. Market Estimation, 2015 – 2018

10.2.3.5.1.2. Market Forecast, 2019 – 2027

10.2.3.5.2. Europe

10.2.3.5.2.1. Market Estimation, 2015 – 2018

10.2.3.5.2.2. Market Forecast, 2019 – 2027

10.2.3.5.3. Asia Pacific

10.2.3.5.3.1. Market Estimation, 2015 – 2018

10.2.3.5.3.2. Market Forecast, 2019 – 2027

10.2.3.5.4. Middle East and Africa

10.2.3.5.4.1. Market Estimation, 2015 – 2018

10.2.3.5.4.2. Market Forecast, 2019 – 2027

10.2.3.5.5. Latin America

10.2.3.5.5.1. Market Estimation, 2015 – 2018

10.2.3.5.5.2. Market Forecast, 2019 – 2027

10.2.4. Others

10.2.4.1. Definition

10.2.4.2. Market Estimation and Penetration, 2015 – 2018

10.2.4.3. Market Forecast, 2019 – 2027

10.2.4.4. Compound Annual Growth Rate (CAGR)

10.2.4.5. Regional Bifurcation

10.2.4.5.1. North America

10.2.4.5.1.1. Market Estimation, 2015 – 2018

10.2.4.5.1.2. Market Forecast, 2019 – 2027

10.2.4.5.2. Europe

10.2.4.5.2.1. Market Estimation, 2015 – 2018

10.2.4.5.2.2. Market Forecast, 2019 – 2027

10.2.4.5.3. Asia Pacific

10.2.4.5.3.1. Market Estimation, 2015 – 2018

10.2.4.5.3.2. Market Forecast, 2019 – 2027

10.2.4.5.4. Middle East and Africa

10.2.4.5.4.1. Market Estimation, 2015 – 2018

10.2.4.5.4.2. Market Forecast, 2019 – 2027

10.2.4.5.5. Latin America

10.2.4.5.5.1. Market Estimation, 2015 – 2018

10.2.4.5.5.2. Market Forecast, 2019 – 2027

10.3. Key Segment for Channeling Investments

10.3.1. By End User

11. North America Inhalation Anesthesia Market Analysis and Forecasts, 2019 - 2027

11.1. Overview

11.1.1. North America Inhalation Anesthesia Market Revenue (US$ Mn)

11.2. North America Inhalation Anesthesia Market Revenue (US$ Mn) and Forecasts, By Product Type

11.2.1. Apparatus

11.2.2. Anesthetics

11.2.2.1. Isoflurane

11.2.2.2. Sevoflurane

11.2.2.3. Desflurane

11.2.2.4. Nitrous Oxide

11.2.2.5. Others

11.2.3. Accessories

11.3. North America Inhalation Anesthesia Market Revenue (US$ Mn) and Forecasts, By Application

11.3.1. Human Healthcare

11.3.1.1. 0 to 1 Months

11.3.1.2. 1 to Less Than 6 Months

11.3.1.3. 6 Months to Less Than 3 Years

11.3.1.4. 3 to 12 Years

11.3.1.5. 12 to 25 Years

11.3.1.6. 25 to 50 Years

11.3.1.7. More than 50 Years

11.3.2. Veterinary Healthcare

11.4. North America Inhalation Anesthesia Market Revenue (US$ Mn) and Forecasts, By End User

11.4.1. Hospitals

11.4.2. Clinics

11.4.3. Ambulatory Surgical Centers

11.4.4. Others

11.5. North America Inhalation Anesthesia Market Revenue (US$ Mn) and Forecasts, By Country

11.5.1. U.S

11.5.1.1. U.S Inhalation Anesthesia Market Revenue (US$ Mn) and Forecasts, By Product Type

11.5.1.1.1. Apparatus

11.5.1.1.2. Anesthetics

11.5.1.1.2.1. Isoflurane

11.5.1.1.2.2. Sevoflurane

11.5.1.1.2.3. Desflurane

11.5.1.1.2.4. Nitrous Oxide

11.5.1.1.2.5. Others

11.5.1.1.3. Accessories

11.5.1.2. U.S Inhalation Anesthesia Market Revenue (US$ Mn) and Forecasts, By Application

11.5.1.2.1. Human Healthcare

11.5.1.2.1.1. 0 to 1 Months

11.5.1.2.1.2. 1 to Less Than 6 Months

11.5.1.2.1.3. 6 Months to Less Than 3 Years

11.5.1.2.1.4. 3 to 12 Years

11.5.1.2.1.5. 12 to 25 Years

11.5.1.2.1.6. 25 to 50 Years

11.5.1.2.1.7. More than 50 Years

11.5.1.2.2. Veterinary Healthcare

11.5.1.3. U.S Inhalation Anesthesia Market Revenue (US$ Mn) and Forecasts, By End User

11.5.1.3.1. Hospitals

11.5.1.3.2. Clinics

11.5.1.3.3. Ambulatory Surgical Centers

11.5.1.3.4. Others

11.5.2. Canada

11.5.2.1. Canada Inhalation Anesthesia Market Revenue (US$ Mn) and Forecasts, By Product Type

11.5.2.1.1. Apparatus

11.5.2.1.2. Anesthetics

11.5.2.1.2.1. Isoflurane

11.5.2.1.2.2. Sevoflurane

11.5.2.1.2.3. Desflurane

11.5.2.1.2.4. Nitrous Oxide

11.5.2.1.2.5. Others

11.5.2.1.3. Accessories

11.5.2.2. Canada Inhalation Anesthesia Market Revenue (US$ Mn) and Forecasts, By Application

11.5.2.2.1. Human Healthcare

11.5.2.2.1.1. 0 to 1 Months

11.5.2.2.1.2. 1 to Less Than 6 Months

11.5.2.2.1.3. 6 Months to Less Than 3 Years

11.5.2.2.1.4. 3 to 12 Years

11.5.2.2.1.5. 12 to 25 Years

11.5.2.2.1.6. 25 to 50 Years

11.5.2.2.1.7. More than 50 Years

11.5.2.2.2. Veterinary Healthcare

11.5.2.3. Canada Inhalation Anesthesia Market Revenue (US$ Mn) and Forecasts, By End User

11.5.2.3.1. Hospitals

11.5.2.3.2. Clinics

11.5.2.3.3. Ambulatory Surgical Centers

11.5.2.3.4. Others

11.5.3. Mexico

11.5.3.1. Mexico Inhalation Anesthesia Market Revenue (US$ Mn) and Forecasts, By Product Type

11.5.3.1.1. Apparatus

11.5.3.1.2. Anesthetics

11.5.3.1.2.1. Isoflurane

11.5.3.1.2.2. Sevoflurane

11.5.3.1.2.3. Desflurane